May 06, 2021

Starpharma (ASX:SPL) launches antiviral nasal spray in Europe

Starpharma (ASX:SPL) launches antiviral nasal spray in Europe

The Market Herald reported on Starpharma's launch of VIRALEZE™  in Europe. Read the full article here.

  • Starpharma’s (SPL) antiviral nasal spray is now available for purchase by consumers in Europe via the company’s online store
  • VIRALEZE is a broad spectrum antiviral nasal spray, which studies have shown can inactivate more than 99.9 per cent of coronavirus pathogens within one minute
  • The product is already available online in the U.K. and through Lloyds Pharmacy’s 1400 stores, with the company now pursuing avenues to provide rapid access for VIRALEZE in India
  • Starpharma shares are up 3.93 per cent, trading at $1.85

 

 This contains certain forward-looking statements.